Fundraising Fox

SiteOne Therapeutics

Bozeman, US · Founded 2014 · Delaware corporation · 4 known investors

Deep tech company; invested from Fund I in 2015

Biotech

Founders & leadership

SiteOne Therapeutics was founded in 2014 by Justin DuBois.

JD
Justin DuBoisFounder
GM
George MiljanichExecutive
SA
Stan AbelExecutive

Board

WPWill Price
Will Pricein𝕏Board MemberInvestor at Next Frontier Capital
LS
Lowell SearsBoard director
JZ
Joseph ZakrzewskiBoard director
RO
Rick OrrBoard director

Investors · 4

Next Frontier CapitalBozeman · $2M – $5M
Mission BiocapitalreportedSan Francisco · $500K
Novo Holdingsreported · 2 sourcesCopenhagen · $1.1M – $54M
OrbiMedreportedNew York · $1M – $75M

Funding

SEC filings, press & company announcements

$116.1M disclosed across 3 of 4 rounds · 2015–2024

▶$14.9MraisedFeb 2017 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph ZakrzewskiDirector
  • Lowell SearsDirector
  • Justin Du BoisDirector
  • John MulcahyExecutive Officer
  • Stan E. AbelExecutive Officer, Director
  • Will PriceDirector
  • Rick OrrDirector
Offering amount
$15.1M
Amount sold
$14.9M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJul 2015 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph ZakrzewskiDirector
  • Will PriceDirector
  • Justin DuBoisDirector
  • Rick OrrDirector
  • George MiljanichExecutive Officer
  • Lowell SearsDirector
  • Stan AbelExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Pain drugmaker Latigo outlines plans to go public | BioPharma Divebiopharmadive.com · Jul 2026SiteOne Therapeutics: $100 Million (Series C) Raised For Advancing Selective Ion Channel Modulators For Pain Managementpulse2.com · Dec 2024SiteOne Therapeutics Raises $100M to Advance Non-Opioid Pain Therapies Targeting Sodium Channelstrial.medpath.com · Dec 2024Novo Holdings leads SiteOne's $100M series C for non-opioid pain treatmentsfiercebiotech.com · Dec 2024SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Painbusinesswire.com · Dec 2024SiteOne Therapeutics Raises $100M in Series C Financingfinsmes.com · Dec 2024

Frequently asked questions

What does SiteOne Therapeutics do?
Deep tech company; invested from Fund I in 2015
Who founded SiteOne Therapeutics?
SiteOne Therapeutics was founded by Justin DuBois in 2014.
Who are SiteOne Therapeutics's investors?
SiteOne Therapeutics's investors include Next Frontier Capital, Mission Biocapital, Novo Holdings, OrbiMed.
How much funding has SiteOne Therapeutics raised?
SiteOne Therapeutics has disclosed $116.1M raised across 3 of its 4 known rounds.
Where is SiteOne Therapeutics headquartered?
SiteOne Therapeutics is headquartered in Bozeman, US.